Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 7 of 20
BREATHE: An Efficacy-implementation With Listening Sessions
NCT05045690
Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors
NCT03626766
BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
NCT04930666
Priming and Patient Reported Outcome Measures
NCT05229016
Microvascular Reactivity in Peripheral Artery Disease
NCT05063474
Tele-Rehabilitation Home Exercise Program for Ambulatory Adults With Cerebral Palsy
NCT05098379
Web Based Therapist Tutorial on Prolonged Grief
NCT05121792
Lasix for the Prevention of De Novo Postpartum Hypertension
NCT04752475
The Reducing Exercise Sensitivity With Exposure Training (RESET) Study
NCT05099926
Sleeping Healthy/Living Healthy Development
NCT04484649
Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD
NCT04786184
Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries
NCT05323123
Sleep Duration and Blood Pressure During Sleep
NCT05062161
Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children
NCT04586504
Effect of Training on Brain Volume in Ataxia
NCT04837027
Clinical Decision Support to Reduce Catheter Associated Urinary Tract Infections
NCT06454500
Information About Alzheimer's Disease for Latinos in New York City
NCT04471779
Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension
NCT05155852
Pediatric Helmet CPAP Pilot Study
NCT04764929
Implementation Science Approach to Enhancing Depression Treatment in Collaborative Depression Care Settings ( DepCare )
NCT05085886
Depression Screening in Black Churches
NCT04524767
COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
NCT05121662
Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)
NCT04804709
A Trial of an Adolescent Male Sexual Health Intervention
NCT04969289
Kidpower Camp - Structured Games or Playgroup
NCT04960813
Evaluation of Diet and Sleep in Vascular Health: A Pilot Study
NCT04990973
Effect of Antihistamines on Ureteral Stent-Related Symptoms
NCT04726345
Video Consultation to Reduce Drug Interactions Among Patients Initiating Oral Anti-Cancer Drugs
NCT05299671
Community Health Worker And MHealth to ImProve Viral Suppression
NCT04562649
Glucose, Activity, Diet, & Sleep Assessment Study
NCT05139264
Study of the Implementation of Telehealth-Supported LARC Provision in School-Based Health Centers
NCT04840836
Welch Emotional Connection Screen (WECS) in the NICU
NCT04922242
Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms
NCT04628832
CLC Parent-Child Emotional Preparation Program
NCT04626037
Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods
NCT04703790
Hair Care Product Use Among Women Of Color
NCT04493892
Nasal Bridge Pressure Injury Prevention
NCT04761679
Attitudes Behavior and Practices of Mothering Among an Online Panel
NCT04871659
Stellate Ganglion Blockade to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors
NCT04582396
Perioperative Local Anesthesia Block in Spine Surgery
NCT05094427
Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
NCT04805840
Understanding Adoption for Clean Cookstoves: A Demand Study
NCT04454944
TXA127 for the Treatment of Severe COVID-19
NCT04401423
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
NCT05524844
Exploratory Evaluation of [11C]MPC6827
NCT04575727
COVID-19 SARS-CoV-2 RAST Study
NCT06452056
Mobile Integrated Health in Heart Failure
NCT04662541
Computer-Assisted Fixation of Trochanteric Femur Fractures
NCT04528459
COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry
NCT04661657
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing
NCT04554121
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.